Methylphenidate

Methylphenidate, the active ingredient in Methylphenidate, is a central nervous system stimulant presented as an oral formulation for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy, helping to improve focus and reduce excessive daytime sleepiness in children, adolescents, and adults.

GNH USA supplies Methylphenidate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides batch‑tested product for global distribution.

Methylphenidate is a central nervous system stimulant used primarily in disorders involving attention regulation and wakefulness.

- Attention deficit hyperactivity disorder (ADHD) in children and adolescents: Improves attention, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (ADHD) in adults: Enhances focus and reduces distractibility. - Narcolepsy: Decreases excessive daytime sleepiness and improves alertness.

Methylphenidate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate head pain. - Stomach upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, hypertension, or tachycardia. - Psychiatric symptoms: psychosis, severe anxiety, or mood swings. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing methylphenidate, several precautions should be observed to ensure safe use. - Cardiovascular assessment: evaluate blood pressure and heart rate before initiating therapy. - Psychiatric history: screen for anxiety, depression, or psychotic disorders. - Substance abuse: avoid use in patients with a history of drug dependence. - Growth monitoring: regularly assess height and weight in children. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Methylphenidate can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular side effects. - Antihypertensive agents: can reduce blood pressure control.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect absorption. - Anticonvulsants (e.g., carbamazepine): may decrease methylphenidate levels. - CYP2D6 inhibitors (e.g., fluoxetine): may increase plasma concentrations.